Allspring Global Investments
KZR

Allspring Global Investments’s Kezar Life Sciences KZR Stock Holding History

Allspring Global Investments’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-224
Closed -$15.8K – 2859
2022
Q4 		$15.8K Sell
224
-1,635
-88% -$121K ﹤0.01% 2638
2022
Q3 		$160K Buy
1,859
+50
+3% +$4.86K ﹤0.01% 1891
2022
Q2 		$149K Sell
1,809
-875
-33% -$77.2K ﹤0.01% 1921
2022
Q1 		$445K Buy
2,684
+461
+21% +$66.2K ﹤0.01% 2276
2021
Q4 		$371K Buy
+2,223
New +$251K ﹤0.01% 2418

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Allspring Global Investments's KZR Position: Q1 2023 in Review

Allspring Global Investments sold out of Kezar Life Sciences (KZR) in Q1 2023, closing a stake of 224 shares — an estimated $15.8K sold.

Allspring Global Investments first reported a position in KZR in Q4 2021 and held it in 5 quarters. The position peaked at $445K in Q1 2022. 136 funds tracked by Wall St. Rank hold KZR as of Q1 2023.

  • Allspring Global Investments reported no remaining Kezar Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Allspring Global Investments sold 224 Kezar Life Sciences shares in Q1 2023, an estimated $15.8K.
  • Allspring Global Investments first reported a position in Kezar Life Sciences in Q4 2021 and held it in 5 quarters.
  • Allspring Global Investments's Kezar Life Sciences position peaked at $445K in Q1 2022.
  • 136 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2023.

Based on Allspring Global Investments's 13F filing for Q1 2023, filed 13 Apr 2023.